News | April 11, 2025
Orchid Pharma to settle disputes with DBS Bank
The company has entered into above Memo to settle, compromise and finally and forever resolve all disputes
The company has entered into above Memo to settle, compromise and finally and forever resolve all disputes
Strengthening capabilities in Peptide Therapeutics and CDMO services
The board of directors accepted Hrosz’s resignation and expressed appreciation for his significant contributions during his tenure
Shilpa’s product has been approved as a generic version to the innovator - Chantix Tablets, 0.5 mg and 1 mg, of PF Prism C.V. (PF Prism)
This partnership encompasses dossier licensing, bulk product supply, and the licensing of ZIM Labs’ proprietary Oral Thin Film technology platform, ThinOral
Introduces revolutionary approach to workflow management to enhance operational efficiency and optimize process efficiency
Mantri will replace V. S. Mani, Executive Director & Global Chief Financial Officer of the company as he has conveyed his decision to opt for early retirement
NATCO has decided to price the product at Rs.15, 900 MRP consistent with the company’s stand before the court
Pregabalin Gel 8% is a novel topical solution for diabetic neuropathic pain
Dr Reddy’s said scheme of amalgamation was carried with adherence to all the legal requirements including tax laws
Subscribe To Our Newsletter & Stay Updated
